| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 753,880 | 721,599 | 752,268 | 812,710 | | Cost of Revenue | 641,117 | 614,545 | 644,718 | 695,762 | | | Gross Profit | 112,763 | 107,054 | 107,550 | 116,948 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 93,394 | 98,385 | 92,530 | 100,752 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 19,369 | 8,669 | 15,020 | 16,196 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,065 | 440 | (496) | (564) | | Earnings Before Interest And Taxes | 20,434 | 9,109 | 14,524 | 15,632 | | Interest Expense | 113 | 149 | 158 | 305 | | Income Before Tax | 20,321 | 8,960 | 14,366 | 15,327 | | Income Tax Expense | 7,723 | 2,469 | 5,668 | 5,359 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 12,598 | 6,491 | 8,698 | 9,968 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 12,598 | 6,491 | 8,698 | 9,968 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $12,598 | $6,491 | $8,698 | $9,968 |
|
0.31% Nasdaq 
0.05%
Income Statement
